Display options
Cite
Kassir R, Rebibo L, Genser L, et al. Recommandations de la SOFFCO-MM en vue de la reprise de l’activité de chirurgie bariatrique et métabolique pendant et après la pandémie Covid-19. [SOFFCO-MM guidelines for the resumption of bariatric and metabolic surgery during and after the Covid-19 pandemic]. J Chir Visc. 2020;157(4):323-334doi: 10.1016/j.jchirv.2020.05.002.
Kassir, R., Rebibo, L., Genser, L., Sterkers, A., Blanchet, M. C., Pattou, F., Msika, S. (2020). Recommandations de la SOFFCO-MM en vue de la reprise de l’activité de chirurgie bariatrique et métabolique pendant et après la pandémie Covid-19. [SOFFCO-MM guidelines for the resumption of bariatric and metabolic surgery during and after the Covid-19 pandemic]. Journal de chirurgie viscerale, 157(4), 323-334. https://doi.org/10.1016/j.jchirv.2020.05.002
Kassir, R, et al. "Recommandations de la SOFFCO-MM en vue de la reprise de l’activité de chirurgie bariatrique et métabolique pendant et après la pandémie Covid-19." [SOFFCO-MM guidelines for the resumption of bariatric and metabolic surgery during and after the Covid-19 pandemic]. Journal de chirurgie viscerale vol. 157,4 (2020): 323-334. doi: https://doi.org/10.1016/j.jchirv.2020.05.002
Kassir R, Rebibo L, Genser L, Sterkers A, Blanchet MC, Pattou F, Msika S. Recommandations de la SOFFCO-MM en vue de la reprise de l’activité de chirurgie bariatrique et métabolique pendant et après la pandémie Covid-19. [SOFFCO-MM guidelines for the resumption of bariatric and metabolic surgery during and after the Covid-19 pandemic]. J Chir Visc. 2020 Aug;157(4):323-334. doi: 10.1016/j.jchirv.2020.05.002. Epub 2020 Jun 05. French. PMID: 32834886; PMCID: PMC7274597.
Copy Download .nbib Format: NLM
Share it on

J Chir Visc. 2020 Aug;157(4):323-334. doi: 10.1016/j.jchirv.2020.05.002. Epub 2020 Jun 05.

[SOFFCO-MM guidelines for the resumption of bariatric and metabolic surgery during and after the Covid-19 pandemic].

Journal de chirurgie viscerale

[Article in French]
R Kassir, L Rebibo, L Genser, A Sterkers, M-C Blanchet, F Pattou, S Msika,

Affiliations

  1. Service de chirurgie digestive et bariatrique, hôpital Felix-Guyon, CHU de la Réunion, La Réunion, France.
  2. Service de chirurgie digestive œsogastrique et bariatique, hôpital Bichat - Claude-Bernard, Paris, France.
  3. Inserm UMR 1149, université de Paris, 75018 Paris, France.
  4. Service de chirurgie digestive hépato-bilio-pancréatique et transplantation hépatique, hôpital universitaire, Sorbonne université, Assistance publique-Hôpitaux de Paris, Pitié-Salpêtrière, Paris, France.
  5. Service de chirurgie digestive et hépatobiliaire, centre hospitalier Privé Saint-Grégoire, Saint-Grégoire, France.
  6. Centre Lyonnais de chirurgie digestive, CSO Sauvegarde Lyon, Lyon, France.
  7. Service de chirurgie générale et endocrinienne, CHU de Lille, Lille, France.
  8. Inserm, Lille Pasteur Institute, EGID, U1190, université Lille, CHU Lille, Lille, France.

PMID: 32834886 PMCID: PMC7274597 DOI: 10.1016/j.jchirv.2020.05.002

Abstract

Bariatric/metabolic surgery was paused during the Covid-19 pandemic. The impact of social confinement and the interruption of this surgery on the population with obesity has been underestimated, with weight gain and worsened comorbidities. Some candidates for this surgery are exposed to a high risk of mortality linked to the pandemic. Obesity and diabetes are two major risk factors for severe forms of Covid-19. The only currently effective treatment for obesity is metabolic surgery, which confers prompt, lasting benefits. It is thus necessary to resume such surgery. To ensure that this resumption is both gradual and well-founded, we have devised a priority ranking plan. The flow charts we propose will help centres to identify priority patients according to a benefit/risk assessment. Diabetes holds a central place in the decision tree. Resumption patterns will vary from one centre to another according to human, physical and medical resources, and will need adjustment as the epidemic unfolds. Specific informed consent will be required. Screening of patients with obesity should be considered, based on available knowledge. If Covid-19 is suspected, surgery must be postponed. Emphasis must be placed on infection control measures to protect patients and healthcare professionals. Confinement is strongly advocated for patients for the first month post-operatively. Patient follow-up should preferably be by teleconsultation.

© 2020 Elsevier Masson SAS. All rights reserved.

Keywords: Bariatric surgery; Covid-19; Guidelines; Obesity; Pandemic

References

  1. Clin Infect Dis. 2020 Jul 28;71(15):896-897 - PubMed
  2. Obes Surg. 2015 Oct;25(10):1959-65 - PubMed
  3. Ann Surg. 2020 Jul;272(1):e3-e4 - PubMed
  4. JAMA. 2018 Jan 16;319(3):291-301 - PubMed
  5. Surg Obes Relat Dis. 2007 Mar-Apr;3(2):134-40 - PubMed
  6. Obes Surg. 2018 Apr;28(4):1175-1184 - PubMed
  7. N Engl J Med. 2007 Aug 23;357(8):741-52 - PubMed
  8. Brain Behav Immun. 2020 Jul;87:18-22 - PubMed
  9. Obesity (Silver Spring). 2020 Jul;28(7):1195-1199 - PubMed
  10. Surg Obes Relat Dis. 2015 Mar-Apr;11(2):335-42 - PubMed
  11. Obes Surg. 2018 Aug;28(8):2233-2240 - PubMed
  12. Appl Physiol Nutr Metab. 2011 Aug;36(4):570-6 - PubMed
  13. Obes Surg. 2015 Jul;25(7):1271-80 - PubMed
  14. Int J Obes (Lond). 2008 Dec;32 Suppl 7:S93-7 - PubMed
  15. Am J Epidemiol. 2006 Jun 1;163(11):1042-52 - PubMed
  16. JAMA. 2003 Jan 8;289(2):187-93 - PubMed
  17. Surgery. 2016 Feb;159(2):467-74 - PubMed
  18. EClinicalMedicine. 2020 Apr 05;21:100331 - PubMed
  19. Aging (Albany NY). 2020 Apr 8;12(7):6049-6057 - PubMed
  20. Am J Surg. 2014 Dec;208(6):903-10; discussion 909-10 - PubMed
  21. Obes Surg. 2019 Nov;29(11):3514-3522 - PubMed
  22. CMAJ. 2011 Oct 4;183(14):E1059-66 - PubMed
  23. Obes Surg. 2018 Sep;28(9):2789-2795 - PubMed
  24. Surg Obes Relat Dis. 2016 Jan;12(1):84-93 - PubMed
  25. Ann Surg. 2017 Mar;265(3):466-473 - PubMed

Publication Types